A comparative evaluation of a new automated assay for von Willebrand factor activity
- 4 December 2012
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 19 (2), 338-342
- https://doi.org/10.1111/hae.12064
Abstract
The ristocetin cofactor assay (VWF:RCo) is the reference method for assessing von Willebrand factor (VWF) activity in the diagnosis of von Willebrand's Disease (VWD). However, the assay suffers from poor reproducibility and sensitivity at low levels of VWF and is labour intensive. We have undertaken an evaluation of a new immunoturbidimetric VWF activity (VWF:Ac) assay (INNOVANCE(®) VWF Ac. Siemens Healthcare Diagnostics, Marburg, Germany) relative to an established platelet-based VWF:RCo method. Samples from 50 healthy normal subjects, 80 patients with VWD and 50 samples that exhibited 'HIL' (i.e. Haemolysis, Icterus or Lipaemia) were studied. VWF:Ac, VWF:RCo and VWF:Ag were performed on a CS-analyser (Sysmex UK Ltd, Milton Keynes, UK), all reagents were from Siemens Healthcare Diagnostics. The VWF:Ac assay, gave low intra- and inter-assay imprecision (over a 31-day period, n = 200 replicate readings) using commercial normal (Mean 96.2 IU dL(-1), CV < 3.0%) and pathological (Mean 36.1 IU dL(-1), CV < 3.5%) control plasmas. The normal and clinical samples exhibited good correlation between VWF:RCo (range 3-753 IU dL(-1)) and VWF:Ac (rs = 0.97, P < 0.0001), with a mean bias of 5.6 IU dL(-1). Ratios of VWF:Ac and VWF:RCo to VWF:Ag in the VWD samples were comparable, although VWF:Ac had a superior lower level of detection to that of VWF:RCo (3% and 5% respectively). A subset (n = 97) of VWD and HIL samples were analysed for VWF:Ac at two different dilutions to assess the effect on relative potency, no significant difference was observed (P = 0.111). The INNOVANCE(®) VWF Ac assay was shown to be reliable and precise.Keywords
This publication has 20 references indexed in Scilit:
- Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWDBlood, 2011
- Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assayJournal of Thrombosis and Haemostasis, 2010
- Evaluation of an automated platelet-based assay of ristocetin cofactor activityHaemophilia, 2010
- Laboratory Diagnosis and Molecular Classification of von Willebrand DiseaseActa Haematologica, 2009
- Clinical and laboratory diagnosis of von Willebrand disease: A synopsis of the 2008 NHLBI/NIH guidelinesAmerican Journal of Hematology, 2009
- Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand FactorJournal of Thrombosis and Haemostasis, 2006
- Guidelines for the diagnosis and management of von Willebrand disease in ItalyHaemophilia, 2002
- Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand’s diseaseBlood Reviews, 1999
- Von willebrand's disease: laboratory investigation using an improved functional assay for von willebrand factorPathology, 1993
- Quantitative Assay of a Plasma Factor Deficient in von Willebrand's Disease that is Necessary for Platelet Aggregation. RELATIONSHIP TO FACTOR VIII PROCOAGULANT ACTIVITY AND ANTIGEN CONTENTJCI Insight, 1973